Skip to main content

Advertisement

Table 1 Patient Characteristics

From: Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait

Variable Patients N (%) (N = 48)
Age (years)
 Median 59
Gender
 Female 28 (58.3%)
 Male 20 (41.7%)
Performance status (ECOG)
 0 8 (21.1%)
 1 13 (34.2%)
 2 10 (26.3%)
 3+ 7 (18.4%)
Number of metastatic sites
 1 15 (31.3%)
 2 8 (16.7%)
 3+ 25 (52%)
Lactate dehydrogenase (IU/L)
 Normal (≤ 618) 33 (75%)
 High (> 618) 11 (25%)
Neutrophil-lymphocyte ratio
 Low (≤ 5) 33 (71.7%)
 High (>  5) 13 (28.3%)
Sites of metastasis
 Lung 13 (27.1%)
 Liver 10 (20.8%)
 Bone 20 (41.7%)
 Lymph node 24 (50%)
First line treatment
 Surgery 9 (26.5%)
 Radiation 8 (23.5%)
 Gemcitabine + Docetaxel 6 (17.6%)
 Taxane + Platinum 4 (11.8%)
 Gemcitabine + Platinum 3 (8.8%)
 Other chemotherapy 4 (11.8%)
  1. Note: If numbers do not add up to 48, it is due to missing data. Percentages reflect cases with available data